0
Capricor Therapeutics, Inc. has reached its limit for free report views
Work for Capricor Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.
Capricor Therapeutics, Inc.
- 11-50 Employees
- Based in Los Angeles, California
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and…More
Capricor Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2020 Annual Report and Form 10K
Report Locked. Capricor Therapeutics, Inc. has reached its limit for free report views.
